191 related articles for article (PubMed ID: 31813263)
21. Future novel therapeutic agents for Clostridium difficile infection.
Koo HL; Garey KW; Dupont HL
Expert Opin Investig Drugs; 2010 Jul; 19(7):825-36. PubMed ID: 20521993
[TBL] [Abstract][Full Text] [Related]
22. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
23. The mechanisms and safety of probiotics against toxigenic
Liu D; Zeng L; Yan Z; Jia J; Gao J; Wei Y
Expert Rev Anti Infect Ther; 2020 Oct; 18(10):967-975. PubMed ID: 32520637
[TBL] [Abstract][Full Text] [Related]
24. Established and potential risk factors for Clostridum difficile infection.
Vaishnavi C
Indian J Med Microbiol; 2009; 27(4):289-300. PubMed ID: 19736396
[TBL] [Abstract][Full Text] [Related]
25. Novel risk factors for recurrent Clostridium difficile infection in children.
Nicholson MR; Thomsen IP; Slaughter JC; Creech CB; Edwards KM
J Pediatr Gastroenterol Nutr; 2015 Jan; 60(1):18-22. PubMed ID: 25199038
[TBL] [Abstract][Full Text] [Related]
26. Clostridium difficile infection in critically injured trauma patients.
Lumpkins K; Bochicchio GV; Joshi M; Gens R; Bochicchio K; Conway A; Schaub S; Scalea T
Surg Infect (Larchmt); 2008 Oct; 9(5):497-501. PubMed ID: 18687049
[TBL] [Abstract][Full Text] [Related]
27. Bacteriophage endolysins as a potential weapon to combat
Mondal SI; Draper LA; Ross RP; Hill C
Gut Microbes; 2020 Nov; 12(1):1813533. PubMed ID: 32985336
[No Abstract] [Full Text] [Related]
28. Long-Term Antibiotic Prophylaxis in Urology and High Incidence of
Jachowicz E; Wałaszek M; Sulimka G; Maciejczak A; Zieńczuk W; Kołodziej D; Karaś J; Pobiega M; Wojkowska-Mach J
Microorganisms; 2020 May; 8(6):. PubMed ID: 32481654
[TBL] [Abstract][Full Text] [Related]
29. Does doxycycline protect against development of Clostridium difficile infection?
Doernberg SB; Winston LG; Deck DH; Chambers HF
Clin Infect Dis; 2012 Sep; 55(5):615-20. PubMed ID: 22563022
[TBL] [Abstract][Full Text] [Related]
30. Epidemiology of Clostridium difficile infections in a tertiary-care hospital in Korea.
Kim J; Kang JO; Kim H; Seo MR; Choi TY; Pai H; Kuijper EJ; Sanders I; Fawley W
Clin Microbiol Infect; 2013 Jun; 19(6):521-7. PubMed ID: 22712697
[TBL] [Abstract][Full Text] [Related]
31. Australasian Society for Infectious Diseases guidelines for the diagnosis and treatment of Clostridium difficile infection.
Cheng AC; Ferguson JK; Richards MJ; Robson JM; Gilbert GL; McGregor A; Roberts S; Korman TM; Riley TV;
Med J Aust; 2011 Apr; 194(7):353-8. PubMed ID: 21470086
[TBL] [Abstract][Full Text] [Related]
32. Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.
Wang J; Ghali S; Xu C; Mussatto CC; Ortiz C; Lee EC; Tran DH; Jacobs JP; Lagishetty V; Faull KF; Moller T; Rossetti M; Chen X; Koon HW
Gastroenterology; 2018 May; 154(6):1737-1750. PubMed ID: 29360463
[TBL] [Abstract][Full Text] [Related]
33. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
34. In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.
Carman RJ; Boone JH; Grover H; Wickham KN; Chen L
Antimicrob Agents Chemother; 2012 Nov; 56(11):6019-20. PubMed ID: 22908175
[TBL] [Abstract][Full Text] [Related]
35. Community-acquired fulminant colitis caused by binary toxin-producing Clostridium difficile in Japan.
Oguri N; Sakuraba A; Morikubo H; Kikuchi O; Sato T; Tokunaga S; Minowa S; Ikezaki O; Mitsui T; Miura M; Saito D; Hayashida M; Mori H; Osaki T; Kamiya S; Senoh M; Kato H; Hisamatsu T
Clin J Gastroenterol; 2019 Aug; 12(4):325-329. PubMed ID: 30767176
[TBL] [Abstract][Full Text] [Related]
36. Complicated Clostridium difficile colitis in children with cystic fibrosis: association with gastric acid suppression?
Com G; Cetin N; O'Brien CE
J Cyst Fibros; 2014 Jan; 13(1):37-42. PubMed ID: 23993432
[TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile infection in older adults: a review and update on its management.
Kee VR
Am J Geriatr Pharmacother; 2012 Feb; 10(1):14-24. PubMed ID: 22260856
[TBL] [Abstract][Full Text] [Related]
38. Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic review.
Kazanowski M; Smolarek S; Kinnarney F; Grzebieniak Z
Tech Coloproctol; 2014 Mar; 18(3):223-32. PubMed ID: 24178946
[TBL] [Abstract][Full Text] [Related]
39. Treatment of Clostridium difficile infection in pediatric patients.
Esposito S; Umbrello G; Castellazzi L; Principi N
Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):747-55. PubMed ID: 25912469
[TBL] [Abstract][Full Text] [Related]
40. Changes in antibiotic consumption, AMR and Clostridioides difficile infections in a large tertiary-care center following the implementation of institution-specific guidelines for antimicrobial therapy: A nine-year interrupted time series study.
Schönherr SG; Ranft D; Lippmann N; Lübbert C
PLoS One; 2021; 16(10):e0258690. PubMed ID: 34648594
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
